Evidence map›Paper›PMID 36947276›Full record

ArticleLa Radiologia medica2023

Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction.

Anna Palmisano, Corrado Campochiaro, Davide Vignale, Alessandro Tomelleri, Giacomo De Luca, Elisa Bruno, Caterina B Monti, Giulio Cavalli, Lorenzo Dagna, Antonio Esposito

Open access · hybridAbstract read
In one paragraph

Article in La Radiologia medica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Myocarditis in Erdheim-Chester disease.Journal of medicine and life · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anna PalmisanoClinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 58 - 60, 20132, Milan, Italy.
Corrado CampochiaroSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Davide VignaleClinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 58 - 60, 20132, Milan, Italy.
Alessandro TomelleriSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Giacomo De LucaSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Elisa BrunoSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Caterina B MontiDepartment of Biomedical Sciences for Health, Università Degli Studi Di Milano, Milan, Italy.
Giulio CavalliSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Lorenzo DagnaSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Antonio EspositoClinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 58 - 60, 20132, Milan, Italy. esposito.antonio@hsr.it.ORCID http://orcid.org/0000-0002-1170-6266
Vita-Salute San Raffaele University · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeErdheim-Chester disease (ECD) is a rare multisystem histiocytosis, whose cardiovascular involvement has not been systematically characterized so far. We aimed to systematically (qualitatively and quantitatively) describe the features of cardiovascular involvement in a large cohort of ECD patients and to evaluate its impact on myocardial fibrosis extension and cardiac function. MATERIAL AND

methodsAmong 54 patients with biopsy-proven ECD, 29 patients (59 ± 12 years, 79% males) underwent 1.5-T CMR using a standardized protocol for qualitative and quantitative assessment of disease localization, evaluation of atrial and ventricular function, and assessment of non-dense and dense myocardial fibrosis.

resultsThe right atrioventricular (AV) groove was the most commonly affected cardiac site (76%) followed by the right atrial walls (63%), thoracic aorta (59%), and superior vena cava (38%). Right AV groove involvement, encasing the right ventricular artery, was associated with non-dense myocardial fibrosis in the infero-septal (20/26 patients) and the inferior (14/26 patients) mid-basal left ventricular (LV) wall. In two patients with right AV groove localization, LGE revealed myocardial infarction in the same myocardial segments. Three out of five patients with left AV groove involvement had non-dense LGE on the lateral LV mid-basal wall. Bulky right atrial pseudomass was associated with atrial dysfunction and superior and inferior vena cava stenosis.

conclusionsIn ECD patients, AV groove localization is associated with LV wall fibrosis in the downstream coronary territories, suggesting hemodynamic alterations due to coronary encasement. Conversely, atrial pseudomass ECD localizations impact on atrial contractility causing atrial dysfunction and are associated with atrio-caval junction stenosis.

Indexed as

Atrial FibrillationCardiomyopathiesErdheim-Chester DiseaseConstriction, PathologicFemaleFibrosisHumansMaleVena Cava, SuperiorCardiacEdemaErdheim–Chester diseaseFibrosisMagnetic resonance imagingMyocardial infarction

Identifiers

PMID36947276
PMCPMC10119040
OpenAlexW4353015013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.